Medtronic rose +6% after Q2 EPS of $1.36 beat the $1.31 estimate on revenue of $8.96bn vs $8.87bn expected. Strength came from medical-surgical and neurosurgery units. Full year guidance commentary supported sentiment.
Join our Mailing list!
Sign up to get all the latest financial news and business updates.
Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.
